Videos

CURE spoke with Dr. Robert Alter of John Theurer Cancer Center about the best time to explore clinical trials.

During the Blood Cancer Heroes Event, Joe McDonough shared his excitement at being among individuals making meaningful contributions to others’ lives.

Dr. William A. Hall sat down with CURE to discuss the impact of technologies like artificial intelligence on gastrointestinal cancer care.

CURE sat down with Dr. Surbhi Sidana to discuss this treatment combination.

Oya Gilbert, diagnosed with myeloma in 2017, uses advocacy and music to improve awareness, access and support for patients with cancer.

Patients share their experiences with myeloma relapses, discussing coping strategies, emotional challenges, and the importance of proactive communication with doctors.

Patients share their personal journeys and insights on the decision-making process surrounding transplant options for cancer treatment.

At Keck Medicine of USC, surgeons, oncologists and radiation specialists collaborate closely, ensuring individualized care for patients with lung cancer.

Joe McDonough reflects on the bonds he’s formed in the childhood cancer community and what they’ve taught him about empathy and shared experience.

Dr. Elena Elimova discussed data showing 21-month progression-free survival with Ziihera, Tevimbra and chemotherapy for some patients.

Kyle Donahue, who enrolled in a clinical trial at Brigham and Women's Hospital, is now a five-year survivor of brain cancer.

Dr. Benjamin Jon Golas explains that surgery, chemotherapy and radiation form the foundation of curative-intent treatment for patients with pancreas cancer.

Dr. Nadine A. Jackson explains how relatively simple interventions may help close gaps in access to genomics-driven trials across gastrointestinal cancers.

With multiple myeloma treatment evolving rapidly, the role of the care partner in managing the complexity of multiple myeloma is more crucial than ever.

In this segment, multiple myeloma care partners direct others to vital sources of hope and practical information.

Joe McDonough shares what message he hopes families hear when first facing a cancer diagnosis.

Dr. Ian Flinn explains how Lunsumio VELO works, offering an outpatient immunotherapy option with accelerated FDA approval.

Oya Gilbert blends hip-hop and advocacy to raise awareness about myeloma, engage patients, and address broader health issues in underserved communities.

Tukysa may be a patient-friendly option as a first line maintenance treatment for HER2-positive breast cancer, as Dr. Erika Hamilton explained.

Explore the latest advancements in myeloma treatment, emphasizing quadruplet therapy and the significance of specialist care for optimal patient outcomes.

Patients share their experiences on the importance of seeking second opinions and expert care in managing complex myeloma treatments.

Dr. Thejus Jayakrishnan discussed how patients and physicians weigh treatment options in later-line metastatic colorectal cancer.

Mayra Andujar-Delgado shares her 10-year myelofibrosis journey and how 2025 Blood Cancer Hero Dr. Faseeh Khaja empowered her and her husband.

Dr. Elena Elimova discusses how Ziihera-based therapy may change treatment for HER2+ locally advanced or metastatic gastroesophageal adenocarcinoma.

Dr. William A. Hall discusses overtreatment in gastrointestinal cancer care and how AI-driven response assessment is shaping personalized treatment.

Dr. Erika Hamilton spoke with CURE’s editor-in-chief, Dr. Joshua K. Sabari.

Dave Coulier sat down for an interview with CURE to discuss his recent tongue cancer diagnosis and his treatment journey.

Dr. Vinayak Venkataraman sat down for an interview with CURE to discuss the evolving treatment of gastrointestinal stromal tumors.

Colleen Mabasa, a patient with multiple myeloma, discusses her CAR T-cell therapy journey and the pivotal role self-advocacy played in her care.

In reflecting on their journeys, multiple myeloma care partners share crucial insights they wish they’d known sooner.